Autonomous Healthcare Receives FDA De Novo Marketing Authorization for Syncron-E™, the First Device in a New FDA Category of Ventilator Waveform Analysis Software

Autonomous Healthcare today announced that the U.S. Food and Drug Administration (FDA) has granted the De Novo marketing authorization for Syncron-E™, its software that supports respiratory therapists ...
autoweek

Autonomous Vehicles Are Vulnerable to Lidar Hacking, Researchers Say

Autonomous vehicles are still in development by automakers and startups, if a bit slower and less capable than initially quoted a decade ago. As a result, academic researchers are still keen on ...